Your session is about to expire
← Back to Search
Serial Casting for Idiopathic Toe Walking (ITW Trial)
ITW Trial Summary
This trial aims to study the outcomes of treating children with idiopathic toe walking either without surgery (casting) or with surgery. The goal is to see which treatment option leads to better results in terms of
ITW Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ITW Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Which individuals meet the criteria to participate in this experimental study?
"Patients aged between 6 and 18 with a diagnosis of idiopathic toe walking are eligible to participate in this study, which aims to recruit a total of 180 participants."
What is the current number of individuals who are being enrolled in this medical study?
"Indeed, the current data on clinicaltrials.gov confirms that patient recruitment is ongoing for this trial. The initial posting of the trial occurred on January 1st, 2022, and the most recent update was made on March 4th, 2024. This study aims to enroll a total of 180 participants distributed across eight designated locations."
Are there ongoing efforts to enroll participants in this research study?
"Information from clinicaltrials.gov reveals that this research study is actively seeking eligible participants. Its initial posting was on January 1st, 2022, and the most recent update occurred on March 4th, 2024."
In how many different geographical areas can patients access this clinical trial?
"This research project is conducted at 8 medical facilities. Some of the sites are situated in Portland, Chicago, and Philadelphia, among others. Selecting a nearby site for enrollment can reduce travel requirements significantly."
Are individuals above the age of 40 eligible to participate in this study?
"Eligible participants for this clinical trial must be over 6 years of age and under 18 years old."
Share this study with friends
Copy Link
Messenger